API
< Back to all clusters
[HEALTH] · United States, Australia · 2 sources

started · updated

Researchers identify potential biological markers for psychiatric disorders

New scientific studies are uncovering biological pathways that may improve the diagnosis and treatment of psychiatric disorders such as schizophrenia and autism.

A team led by Dr. Akira Sawa at the Johns Hopkins University School of Medicine has identified that ACE proteins, which regulate blood pressure, may serve as objective biomarkers for schizophrenia and psychotic disorders. By utilizing a “reverse translation” approach, the researchers analyzed data from a five-year study of early psychosis patients to connect clinical observations with biological mechanisms.

In a separate study, Australian researchers led by Dr. Jean Giacomotto have used genetically modified zebrafish to model human psychiatric conditions. By manipulating genes shared by humans with schizophrenia and autism, the team observed similar behavioral traits in the fish, including social withdrawal, anxiety, and changes in aggression. These findings suggest that complex social behaviors may be deeply encoded in DNA, potentially opening new avenues for testing treatments.

Entities

Akira Sawa · Jean Giacomotto · Johns Hopkins University School of Medicine